Uveal melanoma with BAP1 mutation

Main Article Content

Jin Soo Andy Song, BSc
Adam Dmytriw, MD, MSc
Hesham Lakosha, MD

Abstract

A 40-year-old, healthy man presented with a darkly pigmented inferior temporal lesion in his right eye for 1 year. The corrected visual acuity, intraocular pressure, and neurological examination were unremarkable. Slit-lamp biomicroscopy showed a demarcated pigmented lesion in the peripheral iris between 6 o'clock and 8 o'clock (A). The estimated basal diameter for this mass measured 4mm x 2.5 mm (B). Ultrasound biomicroscopy (UBM) revealed a mass deriving from the iris stroma without ciliary body involvement, suggesting an iris origin (C). Fine-needle aspiration (FNA) confirmed melanoma with inactivation of the BAP1 gene, increasing the probability of metastasis and prompting treatment. UBM has become crucial in differentiation of uveal melanomas from benign growths, as lesions <3 mm cannot be reliably visualized by other imaging modalities. The patient was treated with brachytherapy using an I-125 plaque. Follow-up UBM 3 years later illustrated successful radiotherapy with a reduced tumor (D).

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Song JSA, Dmytriw A, Lakosha H. Uveal melanoma with BAP1 mutation. Digit J Ophthalmol. 2022;22(2). Accessed February 16, 2025. https://djo.harvard.edu/index.php/djo/article/view/336
Section
Images & Videos